Growth Metrics

Cytek Biosciences (CTKB) EBT Margin (2020 - 2026)

Cytek Biosciences posted quarterly EBT Margin of 39.36% for Q1 2026, down 1219.0% year-on-year from 3.52% in Q1 2025, and down 506.82% on a QoQ basis from 6.49% in Q4 2025.

Cytek Biosciences (CTKB) has 7 years of EBT Margin data on file, last reported at 39.36% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin fell 1219.0% year-over-year to 39.36%; the trailing twelve-month figure through Mar 2026 stood at 17.61% (down 1356.0% YoY), and the FY2025 full-year result was 14.81%, down 1197.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 39.36%, down from 6.49% in the prior quarter.
  • Across five years, EBT Margin topped out at 17.96% in Q4 2024 and bottomed at 39.36% in Q1 2026.
  • The 5-year median for EBT Margin is 9.42% (2022), against an average of 9.36%.
  • The widest annual swing landed in 2024, when EBT Margin surged 1090 bps; it then slumped 2445 bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 8.51% in 2022, then retreated by 17 bps to 7.06% in 2023, then jumped by 154 bps to 17.96% in 2024, then slumped by 136 bps to 6.49% in 2025, then sank by 507 bps to 39.36% in 2026.
  • The last three EBT Margin figures came in at 39.36% (Q1 2026), 6.49% (Q4 2025), and 14.86% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.98%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 14.12%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 15.57%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 22.33%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 27.84%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4.87%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 22.61%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 9.84%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.17%
10 Cytek Biosciences - - 21.25 Mn -39.36%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -39.36%
Dec 31, 2025 -6.49%
Sep 30, 2025 -14.86%
Jun 30, 2025 -14.86%
Mar 31, 2025 -27.18%
Dec 31, 2024 17.96%
Sep 30, 2024 0.30%
Jun 30, 2024 -15.41%
Mar 31, 2024 -20.05%
Dec 31, 2023 7.06%
Sep 30, 2023 -8.72%
Jun 30, 2023 -13.27%
Mar 31, 2023 -24.37%
Dec 31, 2022 8.51%
Sep 30, 2022 4.57%
Jun 30, 2022 -3.49%
Mar 31, 2022 -9.42%
Dec 31, 2021 -0.51%
Sep 30, 2021 6.04%
Jun 30, 2021 10.74%
Mar 31, 2021 0.63%
Dec 31, 2020 -12.53%
Sep 30, 2020 27.48%
Jun 30, 2020 1.00%